# Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion

> **NCT02674243** · PHASE3 · COMPLETED · sponsor: **Chiang Mai University** · enrollment: 60 (actual)

## Conditions studied

- Malignant Pleural Effusion

## Interventions

- **DRUG:** Iodopovidone solution
- **DRUG:** Talc

## Key facts

- **NCT ID:** NCT02674243
- **Lead sponsor:** Chiang Mai University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02674243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02674243, "Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02674243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*